phosphatidylcholines has been researched along with levoleucovorin in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (levoleucovorin) | Trials (levoleucovorin) | Recent Studies (post-2010) (levoleucovorin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 10,988 | 3,248 | 3,796 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fittkau, M; Gerlach, R; Schmoll, HJ | 1 |
1 other study(ies) available for phosphatidylcholines and levoleucovorin
| Article | Year |
|---|---|
Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Female; Fluorouracil; Infusions, Intravenous; Intestinal Mucosa; Leucovorin; Phosphatidylcholines; Rats; Rats, Wistar | 2002 |